Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBIT 2010-2024 | MKKGY

Merck annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Merck EBIT for the quarter ending September 30, 2024 was $1.206B, a 12.63% increase year-over-year.
  • Merck EBIT for the twelve months ending September 30, 2024 was $3.738B, a 9.78% decline year-over-year.
  • Merck 2023 annual EBIT was $3.907B, a 17.11% decline from 2022.
  • Merck 2022 annual EBIT was $4.714B, a 4.64% decline from 2021.
  • Merck 2021 annual EBIT was $4.943B, a 44.97% increase from 2020.
  
Merck Annual EBIT
(Millions of US $)
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly EBIT
(Millions of US $)
2024-09-30 $1,206
2024-06-30 $854
2024-03-31 $1,011
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $6,234
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.527B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.364B 28.23
Chugai Pharmaceutical (CHGCY) Japan $72.468B 28.23
Takeda Pharmaceutical (TAK) Japan $42.160B 8.77
Sandoz Group AG (SDZNY) Switzerland $17.930B 0.00
Astellas Pharma (ALPMY) Japan $17.409B 16.03
United Therapeutics (UTHR) United States $16.082B 15.82
Neurocrine Biosciences (NBIX) United States $13.958B 36.96
Summit Therapeutics (SMMT) United States $13.532B 0.00
Shionogi (SGIOY) Japan $11.859B 11.88
Madrigal Pharmaceuticals (MDGL) United States $6.844B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.477B 0.00
Corcept Therapeutics (CORT) United States $5.236B 39.66
Crinetics Pharmaceuticals (CRNX) United States $4.781B 0.00
PTC Therapeutics (PTCT) United States $3.539B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.817B 0.00
Dyne Therapeutics (DYN) United States $2.591B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.567B 11.63
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.404B 14.37
NewAmsterdam Pharma (NAMS) Netherlands $2.398B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.307B 0.00
Soleno Therapeutics (SLNO) United States $1.971B 0.00
Indivior (INDV) United States $1.723B 7.02
Xencor (XNCR) United States $1.665B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Ocular Therapeutix (OCUL) United States $1.374B 0.00
Harrow (HROW) United States $1.302B 0.00
Guardian Pharmacy Services (GRDN) United States $1.259B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.256B 0.00
Ardelyx (ARDX) United States $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.168B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.060B 0.00
ARS Pharmaceuticals (SPRY) United States $1.041B 0.00
Collegium Pharmaceutical (COLL) United States $0.923B 5.04
Bioventus (BVS) United States $0.863B 27.26
Cronos Group (CRON) Canada $0.788B 0.00
Relay Therapeutics (RLAY) United States $0.720B 0.00
Oruka Therapeutics (ORKA) United States $0.699B 0.00
USANA Health Sciences (USNA) United States $0.694B 12.86
Ironwood Pharmaceuticals (IRWD) United States $0.693B 0.00
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
Tourmaline Bio (TRML) United States $0.529B 0.00
Savara (SVRA) United States $0.527B 0.00
Xeris Biopharma Holdings (XERS) United States $0.516B 0.00
Verve Therapeutics (VERV) United States $0.509B 0.00
Altimmune (ALT) United States $0.506B 0.00
ProKidney (PROK) United States $0.505B 0.00
OmniAb (OABI) United States $0.494B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Siga Technologies (SIGA) United States $0.446B 5.20
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Akebia Therapeutics (AKBA) United States $0.415B 0.00
Korro Bio (KRRO) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.381B 0.00
Jupiter Neurosciences (JUNS) United States $0.347B 0.00
Avita Medical (RCEL) United States $0.335B 0.00
Aquestive Therapeutics (AQST) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.311B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.305B 123.71
4D Molecular Therapeutics (FDMT) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 16.00
Amylyx Pharmaceuticals (AMLX) United States $0.268B 0.00
Larimar Therapeutics (LRMR) United States $0.256B 0.00
Heron Therapeutics (HRTX) United States $0.243B 0.00
Profound Medical (PROF) Canada $0.237B 0.00
Inhibikase Therapeutics (IKT) United States $0.221B 0.00
Lexeo Therapeutics (LXEO) United States $0.221B 0.00
Silence Therapeutics (SLN) United Kingdom $0.215B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Lyell Immunopharma (LYEL) United States $0.188B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Acrivon Therapeutics (ACRV) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
VAXART, INC (VXRT) United States $0.163B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
Metagenomi (MGX) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.137B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Achieve Life Sciences (ACHV) Canada $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.121B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
ElectroCore (ECOR) United States $0.110B 0.00
Inotiv (NOTV) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
Context Therapeutics (CNTX) United States $0.089B 0.00
Century Therapeutics (IPSC) United States $0.088B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Journey Medical (DERM) United States $0.084B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.25
PMV Pharmaceuticals (PMVP) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.069B 0.00
OptiNose (OPTN) United States $0.067B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.067B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
FibroGen (FGEN) United States $0.053B 0.00
Scienture Holdings (SCNX) United States $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
AleAnna (ANNA) United States $0.051B 0.00
Nutriband (NTRB) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.049B 0.00
Surrozen (SRZN) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
BioVie (BIVI) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Traws Pharma (TRAW) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.88